Moscow-Sana
A team of Russian experts has developed a pioneering new biomaterial for the treatment of osteoporosis, with the participation of biologists from the Russian Smart University.
Sputnik agency quoted experts as saying today, "The practical application of (hydroxyapatite) will allow the recovery of lost mineral components from bone tissue, organic components to treat osteoporosis, and the organic component that represents the skeleton of all vital tissues."
The scientists reported that they conducted experimental studies on bone formation in people with osteoporosis after they analyzed specific features of fragile bone structure changes in all its stages.
According to the researchers, the hydroxyapatite technology has been improved and its quality evaluated using the advanced Raman spectroscopy method, noting that there are no analogues for such substances in the treatment of osteoporosis in the world.
It is noteworthy that osteoporosis is a chronic disease accompanied by a gradual decrease in the mineral density of bone tissue. It causes increased fragility and the risk of fracture and is considered the fourth deadliest disease after cardiovascular disease, cancer and diabetes.